JP7819944B2 - Il-2バリアント - Google Patents
Il-2バリアントInfo
- Publication number
- JP7819944B2 JP7819944B2 JP2023501378A JP2023501378A JP7819944B2 JP 7819944 B2 JP7819944 B2 JP 7819944B2 JP 2023501378 A JP2023501378 A JP 2023501378A JP 2023501378 A JP2023501378 A JP 2023501378A JP 7819944 B2 JP7819944 B2 JP 7819944B2
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cancer
- protein
- sequence
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063050068P | 2020-07-09 | 2020-07-09 | |
| US63/050,068 | 2020-07-09 | ||
| PCT/IB2021/056106 WO2022009123A1 (en) | 2020-07-09 | 2021-07-07 | Il-2 variants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534793A JP2023534793A (ja) | 2023-08-14 |
| JP2023534793A5 JP2023534793A5 (cg-RX-API-DMAC7.html) | 2024-07-16 |
| JP7819944B2 true JP7819944B2 (ja) | 2026-02-25 |
Family
ID=79552299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501378A Active JP7819944B2 (ja) | 2020-07-09 | 2021-07-07 | Il-2バリアント |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230242607A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4185605A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7819944B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230037612A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115768788A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022009123A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022053864A1 (en) * | 2020-09-08 | 2022-03-17 | Kwon Byoung S | Pd-1 polypeptide variants |
| TWI815194B (zh) | 2020-10-22 | 2023-09-11 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
| CN114853909A (zh) * | 2022-05-13 | 2022-08-05 | 南京吉盛澳玛生物医药有限公司 | 新型IL-2与INFα和Fc融合蛋白的设计、制备及用途 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018234862A1 (en) | 2017-06-19 | 2018-12-27 | Medicenna Therapeutics Inc. | Uses and methods for il-2 superagonists, agonists, and fusions thereof |
| WO2019239213A2 (en) | 2018-06-01 | 2019-12-19 | Medicenna Therapeutics Inc. | Uses and methods for oncolytic virus targeting of il-4/il-13 and fusions thereof |
| WO2020020783A1 (en) | 2018-07-24 | 2020-01-30 | Biontech Rna Pharmaceuticals Gmbh | Il2 agonists |
| WO2020069398A1 (en) | 2018-09-27 | 2020-04-02 | Akrevia Therapeutics Inc. | Masked cytokine polypeptides |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012088446A1 (en) * | 2010-12-22 | 2012-06-28 | Board Of Trustees Of The Leland Stanford Junior University | Superagonists and antagonists of interleukin-2 |
| CN105440123B (zh) * | 2011-02-10 | 2020-10-09 | 罗切格利卡特公司 | 突变体白介素-2多肽 |
| JP6640834B2 (ja) * | 2014-08-11 | 2020-02-05 | デリニア, インコーポレイテッド | 自己免疫疾患の処置のために調節性t細胞を選択的に活性化させる改変il−2変異体 |
| WO2016100375A2 (en) * | 2014-12-15 | 2016-06-23 | Washington University | Compositions and methods for targeted cytokine delivery |
| JP7765181B2 (ja) * | 2017-12-19 | 2025-11-06 | ゼンコア インコーポレイテッド | 改変されたil-2 fc融合タンパク質 |
| CU24554B1 (es) * | 2018-05-07 | 2021-11-04 | Ct Inmunologia Molecular | Proteínas de fusión compuestas por una muteína de interleucina 2 e interferón tipo 1 |
| CA3098930A1 (en) * | 2018-09-21 | 2020-03-26 | Innovent Biologics (Suzhou) Co., Ltd. | Novel interleukin-2 and use thereof |
| CA3117853A1 (en) * | 2018-10-29 | 2020-05-07 | 1Globe Biomedical Co., Ltd. | Novel rationally designed protein compositions |
| AU2020285636A1 (en) * | 2019-05-24 | 2021-11-04 | Proviva Therapeutics (Hong Kong) Limited | IL-2 compositions and methods of use thereof |
| EP4172216A4 (en) * | 2020-06-24 | 2024-12-04 | Medicenna Therapeutics, Inc. | BIFUNCTIONAL SUPERKINE AND USES THEREOF |
| IL304365B2 (en) * | 2021-03-31 | 2025-04-01 | Hanmi Pharmaceutical Co Ltd | A novel conjugate of an IL2 immunostimulatory analog and method of preparation thereof |
-
2021
- 2021-07-07 JP JP2023501378A patent/JP7819944B2/ja active Active
- 2021-07-07 KR KR1020237004667A patent/KR20230037612A/ko active Pending
- 2021-07-07 EP EP21837391.8A patent/EP4185605A4/en active Pending
- 2021-07-07 US US18/004,575 patent/US20230242607A1/en not_active Abandoned
- 2021-07-07 CN CN202180048794.7A patent/CN115768788A/zh active Pending
- 2021-07-07 WO PCT/IB2021/056106 patent/WO2022009123A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018234862A1 (en) | 2017-06-19 | 2018-12-27 | Medicenna Therapeutics Inc. | Uses and methods for il-2 superagonists, agonists, and fusions thereof |
| WO2019239213A2 (en) | 2018-06-01 | 2019-12-19 | Medicenna Therapeutics Inc. | Uses and methods for oncolytic virus targeting of il-4/il-13 and fusions thereof |
| WO2020020783A1 (en) | 2018-07-24 | 2020-01-30 | Biontech Rna Pharmaceuticals Gmbh | Il2 agonists |
| WO2020069398A1 (en) | 2018-09-27 | 2020-04-02 | Akrevia Therapeutics Inc. | Masked cytokine polypeptides |
Non-Patent Citations (1)
| Title |
|---|
| A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control,Nat Commun.,2019年08月28日 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115768788A (zh) | 2023-03-07 |
| EP4185605A4 (en) | 2024-07-17 |
| WO2022009123A1 (en) | 2022-01-13 |
| KR20230037612A (ko) | 2023-03-16 |
| JP2023534793A (ja) | 2023-08-14 |
| EP4185605A1 (en) | 2023-05-31 |
| WO2022009123A4 (en) | 2022-02-24 |
| US20230242607A1 (en) | 2023-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jin et al. | Emerging new therapeutic antibody derivatives for cancer treatment | |
| CN105492017B (zh) | 靶向经修饰的tnf家族成员 | |
| WO2021213478A1 (zh) | 抗人b7-h3的单克隆抗体及其应用 | |
| US10927183B2 (en) | Anti-human VSIG4 antibodies and uses thereof | |
| WO2023006082A1 (zh) | 抗原靶向、抗cd16a和免疫效应细胞激活三功能融合蛋白及其应用 | |
| US20160297863A1 (en) | Epha3 and multi-valent targeting of tumors | |
| EP3980452A1 (en) | Recombinant 4-1bb binding proteins and their use | |
| JP2023534793A (ja) | Il-2バリアント | |
| TWI922770B (zh) | 雙特異性抗體及其應用 | |
| WO2021244590A1 (zh) | 抗b7-h3抗体及其制备和应用 | |
| TWI877240B (zh) | 人類化抗體或其抗原結合片段、此等之製造方法及用途 | |
| JP2025098135A (ja) | Pd-1ポリペプチド変異体 | |
| US12122845B2 (en) | Anti-HER2/anti-4-1BB bispecific antibodies and uses thereof | |
| CN119301159A (zh) | 重组tim-4蛋白、嵌合抗原受体(car)t细胞递送系统及其制备方法和使用方法 | |
| JP7778081B2 (ja) | Il-18を分泌するgpc3 car-t細胞、並びにそれを作製する方法及び使用する方法 | |
| KR102562878B1 (ko) | 질환 항원이 융합된 단백질 및 이의 용도 | |
| CN110016074B (zh) | Mage-a3人源化t细胞受体 | |
| CN119421898A (zh) | 抗lypd3抗体 | |
| KR20250058686A (ko) | Ct83 항원에 결합하는 car-t 세포 및 이의 용도 | |
| TW202409080A (zh) | 用於治療卵巢癌之組合療法 | |
| HK40103619A (en) | Bispecific epitope binding protein comprising anti-4-1bb antibody and pd-1 protein or fragments thereof and use thereof | |
| CN115960248A (zh) | 一种二聚体融合蛋白及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230307 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240705 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240705 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250619 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250708 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251006 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260106 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260204 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7819944 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |